Showing results (221-230 of 270) with videos related to
Sort By:
Pageof 27
Diabetologia|November 6, 2025
Liver fat content is not elevated in people with type 1 diabetes: the Maastricht StudyNefeli M Dimitropoulou, Magdalena Beran, Simone J P M Eussen, et al.Molecular Genetics and Metabolism Reports|May 20, 2020
Kidney and vascular function in adult patients with hereditary fructose intoleranceNynke Simons, François-Guillaume Debray, Nicolaas C Schaper, et al.Clinical Therapeutics|April 5, 2011
Consensus-based evaluation of clinical significance and management of anticancer drug interactionsFrank G A Jansman, An K L Reyners, Eric N van Roon, et al.American Heart Journal|December 16, 2014
Hemoglobin levels and new-onset heart failure in the communityIjsbrand T Klip, Douwe Postmus, Adriaan A Voors, et al.Journal of Endocrinological Investigation|February 8, 2022
Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1aP I H G Simons, O Valkenburg, I Telgenkamp, et al.Plos Biology|March 11, 2021
Towards precision medicine in diabetes? A critical review of glucotypesAdam Hulman, Yuri D Foreman, Martijn C G J Brouwers, et al.Translational Psychiatry|July 27, 2012
NMDA receptor genotypes associated with the vulnerability to develop dyskinesiaS A Ivanova, A J M Loonen, P Pechlivanoglou, et al.JHEP Reports : Innovation in Hepatology|July 11, 2022
High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type IaMartijn P D Haring, Fabian Peeks, Maaike H Oosterveer, et al.The Journal of Clinical Endocrinology and Metabolism|February 13, 2019
Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled TrialIne Telgenkamp, Yvo H A M Kusters, Casper G Schalkwijk, et al.The Lancet. Diabetes & Endocrinology|June 16, 2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trialJohn R Petrie, Nishi Chaturvedi, Ian Ford, et al.Pageof 27